Home
Patients
Researchers
About
FAQ
Blog
More
Leveraging breakthrough multi-omic tools to uncover individuals’ immune dynamics
ImYoo is a Public Benefit Corporation building a patient driven biodiscovery ecosystem.
We combine at-home sample collection and multiomics
Capturing relevant events as they happen
Understanding the complexities of diseases
Predicting kidney transplant rejection with better immune markers.